Ivabradin Heumann

Ivabradine, the active ingredient in Ivabradin Heumann, is a If channel inhibitor presented as an oral tablet for oral use. It treats chronic stable angina pectoris and heart failure with reduced ejection fraction in adult patients.

GNH USA supplies Ivabradin Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivabradine acts on the cardiac If current to manage specific cardiovascular conditions.

Chronic stable angina pectoris: reduces the frequency of angina attacks and improves exercise tolerance. Heart failure with reduced ejection fraction: lowers heart rate, enhancing functional capacity and decreasing hospitalization risk.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Visual disturbances (phosphenes) or blurred vision. - Headache. - Dizziness. - Fatigue. - Mild bradycardia. - Nausea.

Serious or Rare Side Effects: - Severe bradycardia requiring medical attention. - Atrial fibrillation or other arrhythmias. - Symptomatic hypotension. - Heart block. - Visual loss. - Severe allergic reactions (anaphylaxis).

Careful assessment and monitoring are required before and during therapy.

Cardiac monitoring: obtain baseline heart rate and ECG before initiation. Contraindication in severe hepatic impairment: avoid use due to altered metabolism. Caution in sick sinus syndrome: increased risk of excessive bradycardia. Avoid concomitant strong CYP3A4 inhibitors: may raise plasma levels. Pregnancy and lactation: risk unknown; use only if clearly needed. Store at below 25°C: keep in the original pack, protect from moisture.

Ivabradine can interact with several drug classes, altering its effect on heart rate.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): risk of marked bradycardia. - Other heart‑rate‑lowering agents (e.g., beta‑blockers): may cause severe bradycardia. - AV‑node blockers (e.g., diltiazem, verapamil): increase ivabradine exposure.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): monitor heart rate. - Digoxin: watch for additive bradycardic effect. - Antihypertensives: possible enhanced hypotensive response.